Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice

  • The PLOS ONE Staff

Notice of Republication

An incorrect version of S2 Figure was published and the publisher apologizes for this error. This article was republished on December 11, 2023 to correct this error. Please download this article again to view the correct version.Reference

Reference

  1. 1. Bosman M, Krüger DN, Favere K, De Meyer GRY, Franssen C, Van Craenenbroeck EM, et al. (2023) Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice. PLoS ONE 18(11): e0294848. https://doi.org/10.1371/journal.pone.0294848 pmid:38015959

Citation: The PLOS ONE Staff (2023) Correction: Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice. PLoS ONE 18(12): e0296372. https://doi.org/10.1371/journal.pone.0296372

Published: December 20, 2023

Copyright: © 2023 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.